Second Sight Medical Performance
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
The entity has a beta of 0.74, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Second Sight's returns are expected to increase less than the market. However, during the bear market, the loss of holding Second Sight is expected to be smaller as well. Second Sight Medical right now has a risk of 0.0%. Please validate Second Sight total risk alpha, as well as the relationship between the skewness and day median price , to decide if Second Sight will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Second Sight Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Second Sight is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Quick Ratio | 25.07 | |
| Fifty Two Week Low | 3.4200 | |
| Fifty Two Week High | 10.8210 |
Second |
Second Sight Relative Risk vs. Return Landscape
If you would invest 414.00 in Second Sight Medical on January 20, 2024 and sell it today you would earn a total of 0.00 from holding Second Sight Medical or generate 0.0% return on investment over 90 days. Second Sight Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Second, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Second Sight Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Second Sight's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Second Sight Medical, and traders can use it to determine the average amount a Second Sight's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EYES |
Based on monthly moving average Second Sight is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Second Sight by adding Second Sight to a well-diversified portfolio.
Second Sight Fundamentals Growth
Second Stock prices reflect investors' perceptions of the future prospects and financial health of Second Sight, and Second Sight fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Second Stock performance.
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X | |||
| Revenue | 497 K | |||
| EBITDA | (8.24 M) | |||
| Cash And Equivalents | 59.6 M | |||
| Cash Per Share | 1.51 X | |||
| Total Debt | 199 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (10.38 M) | |||
| Earnings Per Share | (0.72) X | |||
| Total Asset | 28.25 M | |||
| Retained Earnings | (328.85 M) | |||
| Current Asset | 26.76 M | |||
| Current Liabilities | 7.98 M |
About Second Sight Performance
To evaluate Second Sight Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Second Sight generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Second Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Second Sight Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Second's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in the United States and is traded on NAS Exchange. It employs 15 people.Things to note about Second Sight Medical performance evaluation
Checking the ongoing alerts about Second Sight for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Second Sight Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Second Sight Medical is not yet fully synchronised with the market data | |
| Second Sight Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 497 K. Net Loss for the year was (8.29 M) with profit before overhead, payroll, taxes, and interest of 130 K. | |
| Second Sight Medical currently holds about 59.6 M in cash with (10.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. | |
| Roughly 29.0% of the company shares are held by company insiders |
- Analyzing Second Sight's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Second Sight's stock is overvalued or undervalued compared to its peers.
- Examining Second Sight's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Second Sight's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Second Sight's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Second Sight's stock. These opinions can provide insight into Second Sight's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |